AVROBIO, Inc.
https://www.avrobio.com/Biotechnology company developing lentiviral-based gene therapies to treat lysosomal storage disorders (LSDs)
Location: United States, Cambridge
Total raised: $85M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 01.02.2018 | Series B | $60M | - | - |
| 02.08.2016 | Series A | $25M | - | - |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 05.02.2018 | Capitalizi... | Announced Thursday, the raise ... | - | - | medcitynew... |
| 02.02.2018 | Term Sheet... | IPO DELAYS Good morning, Term... | - | - | fortune.co... |
| 01.02.2018 | Avrobio Ra... | Avrobio, a Cambridge, Mass.-ba... | USA | - | finsmes.co... |
| 01.02.2018 | AVROBIO, I... | CAMBRIDGE, Mass.–(BUSINESS WIR... | - | - | aislingcap... |
| 01.02.2018 | AVROBIO, I... | Company to initiate Phase 2 tr... | - | - | svhealthin... |
| 01.02.2018 | AVROBIO Ra... | AVROBIO, Inc., a clinical-stag... | - | - | citybizlis... |
| 02.08.2016 | Avrobio Ra... | Avrobio, Inc., a Cambridge, MA... | USA | - | finsmes.co... |
| 02.08.2016 | AVROBIO Ra... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 18.02.2016 | Avrobio Ra... | Avrobio, a Cambridge, MA and T... | Canada US... | - | finsmes.co... |
| 18.02.2016 | Atlas Vent... | AvroBio’s second program, AVR-... | - | - | medcitynew... |